Bryan Giraudo, Director of Protagonist Therapeutics PTGX, has filed 4 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $5.9M. The latest trade was on 05/08.

BG

BG

Bryan Giraudo

Director

Company

Protagonist Therapeutics PTGX

First filing

23/01/18

Trades

60 trades

Buys / sales

4 / 5

12-month net buying

−$5.9M

Last trade

05/08

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Protagonist TherapeuticsPTGX	Open-market sale	05/07–05/08	05/11	59,130 sh4 trades	$100.10avg.	$5,918,880	No record
Gossamer BioGOSS	Open-market buy	24/06/18	24/06/20	100,000 sh	$0.59	$59,000	+26.3%
Gossamer BioGOSS	Open-market sale	24/03/27	24/03/28	6,430 sh	$1.16	$7,458.8	−6.5%
Gossamer BioGOSS	Open-market buy	23/11/13	23/11/14	200,000 sh	$0.56	$112,000	+111.1%
Gossamer BioGOSS	Open-market buy	23/04/04	23/04/05	55,000 sh	$1.02	$56,100	+77.5%
Gossamer BioGOSS	Open-market buy	23/03/20	23/03/22	50,000 sh	$0.97	$48,500	+238.2%